Immune function markers such as CD4 counts are valuable prognostic indicators, as they reflect both the host’s capacity to tolerate chemotherapy and the biological aggressiveness of lymphoma in HIV-infected patients (76). The gene discussed is CD4; the disease is lymphoma.